4-(5-Chloro-2-fluoropyridin-4-yl)-N-((tetrahydro-2H-pyran-4-yl)methyl)thiazol-2-amine

ID: ALA4289648

PubChem CID: 145986373

Max Phase: Preclinical

Molecular Formula: C14H15ClFN3OS

Molecular Weight: 327.81

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Fc1cc(-c2csc(NCC3CCOCC3)n2)c(Cl)cn1

Standard InChI:  InChI=1S/C14H15ClFN3OS/c15-11-7-17-13(16)5-10(11)12-8-21-14(19-12)18-6-9-1-3-20-4-2-9/h5,7-9H,1-4,6H2,(H,18,19)

Standard InChI Key:  ZTBKQYPIDJISQQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   14.3637   -2.1891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0803   -2.5603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8564   -2.8398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8990   -1.5044    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.1083   -1.7369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9401   -2.9791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9389   -3.8065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6538   -4.2193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3702   -3.8060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3673   -2.9754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6520   -2.5664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2256   -2.5668    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.0853   -4.2174    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.1887   -2.1891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6012   -1.4746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4262   -1.4746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8387   -2.1891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6637   -2.1891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0762   -1.4746    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6637   -0.7602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8387   -0.7602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  1  2  0
  1  4  1  0
  4  5  1  0
  5  2  2  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 10  2  1  0
  6 12  1  0
  9 13  1  0
  1 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4289648

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 327.81

Molecular Weight (Monoisotopic): 327.0608

AlogP: 3.84

#Rotatable Bonds: 4

Polar Surface Area: 47.04

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.88

CX LogP: 3.17

CX LogD: 3.17

Aromatic Rings: 2

Heavy Atoms: 21

QED Weighted: 0.87

Np Likeness Score: -1.79

References

1. Wang B, Wu J, Wu Y, Chen C, Zou F, Wang A, Wu H, Hu Z, Jiang Z, Liu Q, Wang W, Zhang Y, Liu F, Zhao M, Hu J, Huang T, Ge J, Wang L, Ren T, Wang Y, Liu J, Liu Q..  (2018)  Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.,  158  [PMID:30253346] [10.1016/j.ejmech.2018.09.025]

Source

Source(1):

• Scientific Literature